HELP ▲ +14.2% - Cybin D/B/A Helus Pharma
$HELP - Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Helus Pharma rose 14.2% today following news that the company will participate in the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit. Conference participation announcements typically generate investor interest by providing a platform for the company to present its neuropsychiatry pipeline and research progress to institutional investors and industry professionals.
21-SEP-2026 05:15 PM ET
Share this post
More filings for $HELP
HELP ▲ +0.1% - Cybin D/B/A Helus PharmaOct 27, 2026HELP ▼ -2.7% - Cybin D/B/A Helus PharmaOct 21, 2026HELP ▼ -0.2% - Cybin D/B/A Helus PharmaOct 15, 2026HELP ▲ +0.4% - Cybin D/B/A Helus PharmaOct 8, 2026HELP ▲ +1.8% - Cybin D/B/A Helus PharmaOct 1, 2026HELP ▲ +1.0% - Cybin D/B/A Helus PharmaSep 22, 2026
View full $HELP filing history →💬 Comments
Loading comments…
Leave a comment
